List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 12 studies with search of: nplate
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Determination of Safe Dose of Romiplostim (Formerly AMG 531) in Subjects With MDS
Conditions: MDS;   Myelodysplastic Syndromes;   Refractory Cytopenias;   Thrombocytopenia
Intervention: Drug: Romiplostim
2 Recruiting A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
3 Active, not recruiting An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenic Purpura
Intervention: Biological: Romiplostim
4 Recruiting Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Conditions: MDS;   Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Placebo;   Biological: Romiplostim
5 Recruiting Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
Conditions: Hematology;   MDS;   Myelodysplastic Syndromes;   Thrombocytopenia
Intervention: Drug: Romiplostim (formerly AMG 531)
6 Completed Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
Condition: Thrombopenia
Intervention:
7 Completed Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
Condition: Thrombocytopenic Purpura
Intervention: Drug: AMG 531
8 Recruiting AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Condition: Solid Tumors
Interventions: Drug: AMG 531;   Drug: Carboplatin;   Drug: Adriamycin;   Drug: Ifosfamide
9 Recruiting Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: AMG 531;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Placebo
10 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
11 Completed AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Conditions: Thrombocytopenic Purpura;   Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Biological: AMG531;   Drug: Medical Standard of Care for ITP
12 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services